Rainier therapeutics
WebbPrior to joining Rainier, Mr. Myers served as CEO, President and as a director of Cascadian Therapeutics Inc. prior to its acquisition by SeaGen in March of 2024. Mr. Myers also served as CEO of Aerocrine AB, a … Rainier Therapeutics Pharmaceutical Manufacturing San Leandro, California 695 followers Advancing Targeted Therapy for Bladder Cancer Follow See all 2 employees About us Rainier Therapeutics is...
Rainier therapeutics
Did you know?
Webb1 maj 2024 · Rainier Therapeutics, Inc. is a privately-held, clinical stage biotechnology company developing a targeted biologic for the potential treatment of metastatic … WebbGroundbreaking Technology First genetic medicines platform to enable highly targeted delivery to organs, tissues and cells beyond the liver Precision Genetic Medicines …
WebbWe seek to build our pipeline by leveraging insights in single cell RNA sequencing of patient kidney samples, human-derived organoids and new translational models in order to discover and develop therapeutics with mechanisms of action targeted against key kidney disease pathways. WebbRain’s biomarker-driven therapeutic pipeline is composed of an MDM2 inhibitor drug candidate in late-stage clinical trials for various cancer indications.
WebbRainier Therapeutics (formerly BioClin Therapeutics) is a biotechnology company developing targeted therapy for bladder cancer. Its lead program is Vofatamab, a human … WebbRainier Therapeutics was developing a monoclonal antibody for the treatment of genetic orphan and oncology diseases. Development programs included achondroplasia, a rare skeletal condition, and metastatic bladder cancer patients who already have failed first-line chemotherapy. Rainier was acquired by Fusion Pharmaceuticals in 2024.
Webb27 nov. 2024 · Rainier Therapeutics, Inc. is a privately-held, clinical stage biotechnology company developing a targeted biologic for the potential treatment of metastatic and early stage bladder cancer, an ...
WebbRainier Therapeutics was developing a monoclonal antibody for the treatment of genetic orphan and oncology diseases. Development programs included achondroplasia, a rare … significance of biblical blessingsWebbRainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.The company's technology uses … significance of biodiversity parkWebb18 maj 2024 · ReCode is leveraging its SORT LNP platform and nucleic acid technologies for mRNA-mediated replacement and gene correction in target cells, including stem cells. For more information, visit www.recodetx.com and follow us on Twitter @ ReCodeTx and LinkedIn. Investor Contact: Sarah McCabe Stern IR [email protected] … significance of bethel in the bibleWebbis the foundation for our pipeline of disease-modifying mRNA and gene correction therapeutics for genetically defined diseases for which there are few or no current treatments. The SORT LNPs are used to package and deliver genetic medicine cargoes such as mRNA, siRNA, and gene correction modalities. Engineered for Precision and … the public house franklin maWebb3 juni 2024 · Rainier Therapeutics, Inc. is a privately held, clinical stage biotechnology company developing vofatamab, a targeted antibody for the potential treatment of … the public house in 300 s brevardWebb4 juni 2024 · Rainier Therapeutics, Inc. is a privately held, clinical stage biotechnology company developing vofatamab, a targeted antibody, for the potential treatment of metastatic bladder cancer. For more information, please visit www.rainierrx.com. Contacts [email protected] Julie Rathbun Rathbun Communications (206) 769-9291 … the public house new yorkWebbPreviously, he was Chairman and Chief Executive Officer of Rainier Therapeutics, a clinical-stage biotechnology company focused on metastatic bladder cancer. Rainier's asset, … the public house national harbor